NASALLY ADMINISTERED PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF EPILEPSY AND RELATED DISORDERS
申请人:Shaheen, Farzana
公开号:EP3895703A1
公开(公告)日:2021-10-20
A nasally administered liquid, including suspension and viscous liquid compositions, containing a therapeutically effective quantity of (Z)-2-(3,5,5-trimethyl-2-cyclohexen-1-ylidene) acetic acid, its salts or analogs, combined with suitable pharmaceutical ingredients, to treat epilepsy and related CNS disorders.
一种经鼻给药的液体,包括悬浮液和粘稠液体组成,含有治疗有效量的(Z)-2-(3,5,5-三甲基-2-环己烯-1-基)乙酸、其盐或类似物,与适当的药物成分结合,用于治疗癫痫和相关的中枢神经系统疾病。